Skip to content

Author

Eric Jonasch

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

46 TKI Resistance is Associated with Immune Dysfunction in ccRCC

It is observed that sunitinib treatment leads to a marked reduction in endothelial cells and cancer‑associated fibroblasts, confirming a massive collapse of the vascular and perivascular niche, and identified two major tumor cell populations that adapt in distinct ways to sunitinib exposure and the resulting vascular c...

Xian-De Liu, Hong-Chao He, Jing-Jing Liu et al. · 0 citations
Review Open access Sep 2026

62 Patient Experience with Clinical Trials: Results from the International Kidney Cancer Coalition Global Patient Survey

Abstract Background Clinical trials are essential for advancing cancer care, yet patient participation remains suboptimal worldwide. While structural and clinician-reported barriers are well described, patient perspectives across diverse geographic and socioeconomic settings are less understood. The International Kidne...

Eric Jonasch, S. de Cássio Zequi, A. Bex et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.